TrialJAMA2022
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
Ying Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
365 papers cite itlatest 60 shown
this paperpooled ittrialcites it